Management of hyperglycemia in type 2 diabetes: evidence and uncertainty View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-05-30

AUTHORS

Katherine Esposito, Sandro Gentile, Riccardo Candido, Alberto De Micheli, Marco Gallo, Gerardo Medea, Antonio Ceriello

ABSTRACT

The panoply of treatment algorithms, periodically released to improve guidance, is one mean to face therapeutic uncertainty in pharmacological management of hyperglycemia in type 2 diabetes, especially after metformin failure. Failure of recent guidelines to give advice on the use of specific antidiabetic drugs in patients with co-morbidity may generate further uncertainty, given the frequent association of type 2 diabetes with common comorbidity, including, although not limited to obesity, cardiovascular disease, impaired renal function, and frailty. The Italian Association of Diabetologists (Associazione Medici Diabetologi, AMD) recognized the need to develop personalized treatment plans for people with type 2 diabetes, taking into account the patients' individual profile (phenotype), with the objective of the safest possible glycemic control. As not every subject with type 2 diabetes benefits from intensive glycemic control, flexible regimens of treatment with diabetes drugs (including insulin) are needed for reaching individualized glycemic goals. Whether personalized diabetology will improve the quality healthcare practice of diabetes management is unknown, but specific research has been launched. More... »

PAGES

81-81

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1475-2840-12-81

DOI

http://dx.doi.org/10.1186/1475-2840-12-81

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009647582

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23721170


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Algorithms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hyperglycemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Obesity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Care Planning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Practice Guidelines as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Precision Medicine", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy", 
          "id": "http://www.grid.ac/institutes/grid.9841.4", 
          "name": [
            "Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Esposito", 
        "givenName": "Katherine", 
        "id": "sg:person.01225251446.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225251446.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy", 
          "id": "http://www.grid.ac/institutes/grid.9841.4", 
          "name": [
            "Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gentile", 
        "givenName": "Sandro", 
        "id": "sg:person.0722547775.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722547775.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Diabetes Center, A.S.S. 1 Triestina, Trieste, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Diabetes Center, A.S.S. 1 Triestina, Trieste, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Candido", 
        "givenName": "Riccardo", 
        "id": "sg:person.01026702544.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026702544.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ligurian Health Agency, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Ligurian Health Agency, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Micheli", 
        "givenName": "Alberto", 
        "id": "sg:person.01045343317.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045343317.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncological Endocrinology, AO Citt\u00e0 della Salute e della Scienza-Molinette, Turin, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Oncological Endocrinology, AO Citt\u00e0 della Salute e della Scienza-Molinette, Turin, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gallo", 
        "givenName": "Marco", 
        "id": "sg:person.013265021462.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013265021462.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Italian College of General Practitioners (Societ\u00e0 Italiana di Medicina Generale), Florence, Italy", 
          "id": "http://www.grid.ac/institutes/grid.419599.9", 
          "name": [
            "Italian College of General Practitioners (Societ\u00e0 Italiana di Medicina Generale), Florence, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Medea", 
        "givenName": "Gerardo", 
        "id": "sg:person.0721114336.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721114336.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centro de Investigacion Biom\u00e8dica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/grid.430579.c", 
          "name": [
            "Institut d\u2019Investigations Biom\u00e8diques August Pi i Sunyer (IDIBAPS), Barcelona, Spain", 
            "Centro de Investigacion Biom\u00e8dica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ceriello", 
        "givenName": "Antonio", 
        "id": "sg:person.0711436716.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711436716.35"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1475-2840-12-62", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023309205", 
          "https://doi.org/10.1186/1475-2840-12-62"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12020-013-9918-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019993223", 
          "https://doi.org/10.1007/s12020-013-9918-x"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2013-05-30", 
    "datePublishedReg": "2013-05-30", 
    "description": "The panoply of treatment algorithms, periodically released to improve guidance, is one mean to face therapeutic uncertainty in pharmacological management of hyperglycemia in type 2 diabetes, especially after metformin failure. Failure of recent guidelines to give advice on the use of specific antidiabetic drugs in patients with co-morbidity may generate further uncertainty, given the frequent association of type 2 diabetes with common comorbidity, including, although not limited to obesity, cardiovascular disease, impaired renal function, and frailty. The Italian Association of Diabetologists (Associazione Medici Diabetologi, AMD) recognized the need to develop personalized treatment plans for people with type 2 diabetes, taking into account the patients' individual profile (phenotype), with the objective of the safest possible glycemic control. As not every subject with type 2 diabetes benefits from intensive glycemic control, flexible regimens of treatment with diabetes drugs (including insulin) are needed for reaching individualized glycemic goals. Whether personalized diabetology will improve the quality healthcare practice of diabetes management is unknown, but specific research has been launched.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1475-2840-12-81", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031021", 
        "issn": [
          "1475-2840"
        ], 
        "name": "Cardiovascular Diabetology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "12"
      }
    ], 
    "keywords": [
      "type 2 diabetes", 
      "glycemic control", 
      "type 2 diabetes benefit", 
      "patient's individual profile", 
      "individualized glycemic goals", 
      "intensive glycemic control", 
      "management of hyperglycemia", 
      "personalized treatment plans", 
      "metformin failure", 
      "pharmacological management", 
      "renal function", 
      "common comorbidities", 
      "glycemic goals", 
      "treatment algorithm", 
      "diabetes benefit", 
      "therapeutic uncertainty", 
      "recent guidelines", 
      "cardiovascular disease", 
      "flexible regimens", 
      "antidiabetic drugs", 
      "diabetes drugs", 
      "diabetes management", 
      "type 2", 
      "treatment plan", 
      "frequent association", 
      "Italian Association", 
      "diabetes", 
      "hyperglycemia", 
      "healthcare practice", 
      "drugs", 
      "association", 
      "comorbidities", 
      "regimens", 
      "obesity", 
      "diabetologists", 
      "patients", 
      "failure", 
      "individual profiles", 
      "management", 
      "frailty", 
      "diabetology", 
      "disease", 
      "treatment", 
      "control", 
      "subjects", 
      "guidelines", 
      "advice", 
      "evidence", 
      "specific research", 
      "benefits", 
      "guidance", 
      "people", 
      "profile", 
      "objective", 
      "use", 
      "need", 
      "practice", 
      "function", 
      "plan", 
      "panoply", 
      "goal", 
      "means", 
      "research", 
      "further uncertainty", 
      "account", 
      "uncertainty", 
      "algorithm", 
      "specific antidiabetic drugs", 
      "safest possible glycemic control", 
      "possible glycemic control", 
      "personalized diabetology", 
      "quality healthcare practice"
    ], 
    "name": "Management of hyperglycemia in type 2 diabetes: evidence and uncertainty", 
    "pagination": "81-81", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009647582"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1475-2840-12-81"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23721170"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1475-2840-12-81", 
      "https://app.dimensions.ai/details/publication/pub.1009647582"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:31", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_609.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1475-2840-12-81"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1475-2840-12-81'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1475-2840-12-81'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1475-2840-12-81'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1475-2840-12-81'


 

This table displays all metadata directly associated to this object as RDF triples.

233 TRIPLES      22 PREDICATES      109 URIs      99 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1475-2840-12-81 schema:about N153f2a6689fd482eabba038e7498f434
2 N4e1d18de61254fe9ba7ac90d01690e56
3 N96483cd258be46a6ab3900677afaff4a
4 Na2f58b4ec97d4a72b8e8c0e7af37c6c2
5 Na4904446a8c647248edf57742419d5e3
6 Nbf5083eb9e2f43178d0609fea0f1f513
7 Necc6c674630846d68645ba6a951e11e1
8 Nef8a7c4282c146e791cf744d0f524233
9 Nfea5c6133f7a4ab9a80fb94c50e8ede6
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N1c7315db0dd743779ae28ed079ee4d9d
13 schema:citation sg:pub.10.1007/s12020-013-9918-x
14 sg:pub.10.1186/1475-2840-12-62
15 schema:datePublished 2013-05-30
16 schema:datePublishedReg 2013-05-30
17 schema:description The panoply of treatment algorithms, periodically released to improve guidance, is one mean to face therapeutic uncertainty in pharmacological management of hyperglycemia in type 2 diabetes, especially after metformin failure. Failure of recent guidelines to give advice on the use of specific antidiabetic drugs in patients with co-morbidity may generate further uncertainty, given the frequent association of type 2 diabetes with common comorbidity, including, although not limited to obesity, cardiovascular disease, impaired renal function, and frailty. The Italian Association of Diabetologists (Associazione Medici Diabetologi, AMD) recognized the need to develop personalized treatment plans for people with type 2 diabetes, taking into account the patients' individual profile (phenotype), with the objective of the safest possible glycemic control. As not every subject with type 2 diabetes benefits from intensive glycemic control, flexible regimens of treatment with diabetes drugs (including insulin) are needed for reaching individualized glycemic goals. Whether personalized diabetology will improve the quality healthcare practice of diabetes management is unknown, but specific research has been launched.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree true
21 schema:isPartOf N4fb65f4ace6c4e77b92c35cc2ddce1ed
22 N7bf410890ede48af8410c472dd4f27aa
23 sg:journal.1031021
24 schema:keywords Italian Association
25 account
26 advice
27 algorithm
28 antidiabetic drugs
29 association
30 benefits
31 cardiovascular disease
32 common comorbidities
33 comorbidities
34 control
35 diabetes
36 diabetes benefit
37 diabetes drugs
38 diabetes management
39 diabetologists
40 diabetology
41 disease
42 drugs
43 evidence
44 failure
45 flexible regimens
46 frailty
47 frequent association
48 function
49 further uncertainty
50 glycemic control
51 glycemic goals
52 goal
53 guidance
54 guidelines
55 healthcare practice
56 hyperglycemia
57 individual profiles
58 individualized glycemic goals
59 intensive glycemic control
60 management
61 management of hyperglycemia
62 means
63 metformin failure
64 need
65 obesity
66 objective
67 panoply
68 patient's individual profile
69 patients
70 people
71 personalized diabetology
72 personalized treatment plans
73 pharmacological management
74 plan
75 possible glycemic control
76 practice
77 profile
78 quality healthcare practice
79 recent guidelines
80 regimens
81 renal function
82 research
83 safest possible glycemic control
84 specific antidiabetic drugs
85 specific research
86 subjects
87 therapeutic uncertainty
88 treatment
89 treatment algorithm
90 treatment plan
91 type 2
92 type 2 diabetes
93 type 2 diabetes benefit
94 uncertainty
95 use
96 schema:name Management of hyperglycemia in type 2 diabetes: evidence and uncertainty
97 schema:pagination 81-81
98 schema:productId N7068c97fbb3845aea081863b4f000c78
99 Ncbdb7976bcea472ba47db275f4459f8e
100 Ne8b6a5e214b64877913df24ddf7da414
101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009647582
102 https://doi.org/10.1186/1475-2840-12-81
103 schema:sdDatePublished 2022-01-01T18:31
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher N88a3da6de6fb44eb90665a9a9c47d67d
106 schema:url https://doi.org/10.1186/1475-2840-12-81
107 sgo:license sg:explorer/license/
108 sgo:sdDataset articles
109 rdf:type schema:ScholarlyArticle
110 N0958a676396a4227a4d65a22878c4ca1 rdf:first sg:person.0722547775.10
111 rdf:rest N8a74761ee780442f96d7f53de1c3a766
112 N153f2a6689fd482eabba038e7498f434 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Diabetes Mellitus, Type 2
114 rdf:type schema:DefinedTerm
115 N1c7315db0dd743779ae28ed079ee4d9d rdf:first sg:person.01225251446.30
116 rdf:rest N0958a676396a4227a4d65a22878c4ca1
117 N20ca6ebf7c174a309d697f4ee09f38e2 rdf:first sg:person.013265021462.01
118 rdf:rest Naa940831acf9460c9bbbe84a2208972c
119 N4e1d18de61254fe9ba7ac90d01690e56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Hypoglycemic Agents
121 rdf:type schema:DefinedTerm
122 N4fb65f4ace6c4e77b92c35cc2ddce1ed schema:issueNumber 1
123 rdf:type schema:PublicationIssue
124 N7068c97fbb3845aea081863b4f000c78 schema:name doi
125 schema:value 10.1186/1475-2840-12-81
126 rdf:type schema:PropertyValue
127 N7bf410890ede48af8410c472dd4f27aa schema:volumeNumber 12
128 rdf:type schema:PublicationVolume
129 N7f6aa8556b804cfd9fc1dde77837f12a rdf:first sg:person.0711436716.35
130 rdf:rest rdf:nil
131 N88a3da6de6fb44eb90665a9a9c47d67d schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N8a74761ee780442f96d7f53de1c3a766 rdf:first sg:person.01026702544.26
134 rdf:rest Ne647f82ab047404b82cc07ebe818dcfa
135 N96483cd258be46a6ab3900677afaff4a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Obesity
137 rdf:type schema:DefinedTerm
138 Na2f58b4ec97d4a72b8e8c0e7af37c6c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Algorithms
140 rdf:type schema:DefinedTerm
141 Na4904446a8c647248edf57742419d5e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Patient Care Planning
143 rdf:type schema:DefinedTerm
144 Naa940831acf9460c9bbbe84a2208972c rdf:first sg:person.0721114336.32
145 rdf:rest N7f6aa8556b804cfd9fc1dde77837f12a
146 Nbf5083eb9e2f43178d0609fea0f1f513 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Humans
148 rdf:type schema:DefinedTerm
149 Ncbdb7976bcea472ba47db275f4459f8e schema:name dimensions_id
150 schema:value pub.1009647582
151 rdf:type schema:PropertyValue
152 Ne647f82ab047404b82cc07ebe818dcfa rdf:first sg:person.01045343317.13
153 rdf:rest N20ca6ebf7c174a309d697f4ee09f38e2
154 Ne8b6a5e214b64877913df24ddf7da414 schema:name pubmed_id
155 schema:value 23721170
156 rdf:type schema:PropertyValue
157 Necc6c674630846d68645ba6a951e11e1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Precision Medicine
159 rdf:type schema:DefinedTerm
160 Nef8a7c4282c146e791cf744d0f524233 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Practice Guidelines as Topic
162 rdf:type schema:DefinedTerm
163 Nfea5c6133f7a4ab9a80fb94c50e8ede6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Hyperglycemia
165 rdf:type schema:DefinedTerm
166 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
167 schema:name Medical and Health Sciences
168 rdf:type schema:DefinedTerm
169 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
170 schema:name Clinical Sciences
171 rdf:type schema:DefinedTerm
172 sg:journal.1031021 schema:issn 1475-2840
173 schema:name Cardiovascular Diabetology
174 schema:publisher Springer Nature
175 rdf:type schema:Periodical
176 sg:person.01026702544.26 schema:affiliation grid-institutes:None
177 schema:familyName Candido
178 schema:givenName Riccardo
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026702544.26
180 rdf:type schema:Person
181 sg:person.01045343317.13 schema:affiliation grid-institutes:None
182 schema:familyName De Micheli
183 schema:givenName Alberto
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01045343317.13
185 rdf:type schema:Person
186 sg:person.01225251446.30 schema:affiliation grid-institutes:grid.9841.4
187 schema:familyName Esposito
188 schema:givenName Katherine
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225251446.30
190 rdf:type schema:Person
191 sg:person.013265021462.01 schema:affiliation grid-institutes:None
192 schema:familyName Gallo
193 schema:givenName Marco
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013265021462.01
195 rdf:type schema:Person
196 sg:person.0711436716.35 schema:affiliation grid-institutes:grid.430579.c
197 schema:familyName Ceriello
198 schema:givenName Antonio
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0711436716.35
200 rdf:type schema:Person
201 sg:person.0721114336.32 schema:affiliation grid-institutes:grid.419599.9
202 schema:familyName Medea
203 schema:givenName Gerardo
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721114336.32
205 rdf:type schema:Person
206 sg:person.0722547775.10 schema:affiliation grid-institutes:grid.9841.4
207 schema:familyName Gentile
208 schema:givenName Sandro
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722547775.10
210 rdf:type schema:Person
211 sg:pub.10.1007/s12020-013-9918-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1019993223
212 https://doi.org/10.1007/s12020-013-9918-x
213 rdf:type schema:CreativeWork
214 sg:pub.10.1186/1475-2840-12-62 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023309205
215 https://doi.org/10.1186/1475-2840-12-62
216 rdf:type schema:CreativeWork
217 grid-institutes:None schema:alternateName Diabetes Center, A.S.S. 1 Triestina, Trieste, Italy
218 Ligurian Health Agency, Genoa, Italy
219 Oncological Endocrinology, AO Città della Salute e della Scienza-Molinette, Turin, Italy
220 schema:name Diabetes Center, A.S.S. 1 Triestina, Trieste, Italy
221 Ligurian Health Agency, Genoa, Italy
222 Oncological Endocrinology, AO Città della Salute e della Scienza-Molinette, Turin, Italy
223 rdf:type schema:Organization
224 grid-institutes:grid.419599.9 schema:alternateName Italian College of General Practitioners (Società Italiana di Medicina Generale), Florence, Italy
225 schema:name Italian College of General Practitioners (Società Italiana di Medicina Generale), Florence, Italy
226 rdf:type schema:Organization
227 grid-institutes:grid.430579.c schema:alternateName Centro de Investigacion Biomèdica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Barcelona, Spain
228 schema:name Centro de Investigacion Biomèdica en Red de Diabetes y Enfermedades Metabolicas Asociadas (CIBERDEM), Barcelona, Spain
229 Institut d’Investigations Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
230 rdf:type schema:Organization
231 grid-institutes:grid.9841.4 schema:alternateName Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy
232 schema:name Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy
233 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...